Article Versions Notes

Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee J-KJ, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, et al. Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer. Cancers. 2023; 15(2):418. https://doi.org/10.3390/cancers15020418

Mlecnik, Bernhard, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, and et al. 2023. "Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer" Cancers 15, no. 2: 418. https://doi.org/10.3390/cancers15020418

Mlecnik, B., Lugli, A., Bindea, G., Marliot, F., Bifulco, C., Lee, J.-K. J., Zlobec, I., Rau, T. T., Berger, M. D., Nagtegaal, I. D., Vink-Börger, E., Hartmann, A., Geppert, C. I., Kolwelter, J., Merkel, S., Grützmann, R., Van den Eynde, M., Jouret-Mourin, A., Kartheuser, A., ... Galon, J. (2023). Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer. Cancers, 15(2), 418. https://doi.org/10.3390/cancers15020418